Ligand Pharmaceuticals Incorporated
US ˙ NasdaqGM ˙ US53220K5048

SecurityLGND / Ligand Pharmaceuticals Incorporated
InstitutionStrs Ohio
Latest Disclosed Ownership5,800 shares
Latest Disclosed Value $ 1,157,970
Strs Ohio reports 4.92% decrease in ownership of LGND / Ligand Pharmaceuticals Incorporated

On April 24, 2026 - Strs Ohio filed a 13F-HR form disclosing ownership of 5,800 shares of Ligand Pharmaceuticals Incorporated (US:LGND) valued at $1,157,970 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 2, 2026 disclosing 6,100 shares of Ligand Pharmaceuticals Incorporated. This represents a change in shares of -4.92% during the quarter. The current value of the position is $1,359,520 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-24 2026-03-31 13F LIGAND PHARMACEUTICALS COM_STK 53220K504 5,800 -300 -4.92 1,158 0.35 0.0046
2026-02-02 2025-12-31 13F LIGAND PHARMACEUTICALS COM_STK 53220K504 6,100 -400 -6.15 1,153 0.17 0.0043
2025-10-30 2025-09-30 13F LIGAND PHARMACEUTICALS COM_STK 53220K504 6,500 -900 -12.16 1,151 36.86 0.0042
2025-08-04 2025-06-30 13F LIGAND PHARMACEUTICALS COM_STK 53220K504 7,400 -100 -1.33 841 6.73 0.0031
2025-05-28 2025-03-31 13F LIGAND PHARMACEUTICALS COM_STK 53220K504 7,500 0 0.00 789 -1.87 0.0033
2025-05-28 2024-12-31 13F LIGAND PHARMACEUTICALS COM_STK 53220K504 7,500 -600 -7.41 804 -0.86 0.0032
2024-11-01 2024-09-30 13F LIGAND PHARMACEUTICALS COM_STK 53220K504 8,100 -700 -7.95 811 9.31 0.0031
2024-08-05 2024-06-30 13F LIGAND PHARMACEUTICALS COM_STK 53220K504 8,800 -500 -5.38 741 0.0029
2024-05-13 2024-03-31 13F LIGAND PHARMACEUTICALS COM_STK 53220K504 9,300 -1,700 -15.45 1 0.0027
2024-01-30 2023-12-31 13F LIGAND PHARMACEUTICALS COM 53220K504 11,000 -300 -2.65 1 0.0033
2023-10-26 2023-09-30 13F/A-1 LIGAND PHARMACEUTICALS COM 53220K504 11,300 1,500 15.31 1 0.0030
2023-10-26 2023-09-30 13F LIGAND PHARMACEUTICALS COM 53220K504 11,300 1,500 1 0.0030
2023-07-31 2023-06-30 13F LIGAND PHARMACEUTICALS COM 53220K504 9,800 0 0.00 1 0.0030
2023-08-02 2023-03-31 13F/A-2 LIGAND PHARMACEUTICALS COM 53220K504 9,800 -1,200 -10.91 1 0.0031
2023-08-02 2023-03-31 13F/A-1 LIGAND PHARMACEUTICALS COM 53220K504 9,800 1
2023-04-27 2023-03-31 13F LIGAND PHARMACEUTICALS COM 53220K504 9,800 -1,200 1 0.0037
2023-01-26 2022-12-31 13F LIGAND PHARMACEUTICALS COM 53220K504 11,000 3,500 46.67 1 -100.00 0.0033
2022-10-27 2022-09-30 13F LIGAND PHARMACEUTICALS COM 53220K504 7,500 0 0.00 645 -3.59 0.0031
2022-07-25 2022-06-30 13F LIGAND PHARMACEUTICALS COM 53220K504 7,500 400 5.63 669 -16.17 0.0030
2022-04-21 2022-03-31 13F LIGAND PHARMACEUTICALS COM 53220K504 7,100 0 0.00 798 -27.19 0.0029
2022-01-24 2021-12-31 13F LIGAND PHARMACEUTICALS COM 53220K504 7,100 0 0.00 1,096 10.82 0.0038
2021-10-22 2021-09-30 13F LIGAND PHARMACEUTICALS COM 53220K504 7,100 -1,700 -19.32 989 -14.30 0.0037
2021-07-26 2021-06-30 13F LIGAND PHARMACEUTICALS COM 53220K504 8,800 5,800 193.33 1,154 152.52 0.0042
2021-04-23 2021-03-31 13F LIGAND PHARMACEUTICALS COM 53220K504 3,000 3,000 457 0.0017
2019-10-21 2019-09-30 13F LIGAND PHARMACEUTICALS COM 53220K504 0 -300 -100.00 0 -100.00
2019-07-25 2019-06-30 13F LIGAND PHARMACEUTICALS COM 53220K504 300 -1,300 -81.25 34 -83.08 0.0002
2019-04-19 2019-03-31 13F LIGAND PHARMACEUTICALS COM 53220K504 1,600 -48,700 -96.82 201 -97.05 0.0009
2019-01-23 2018-12-31 13F LIGAND PHARMACEUTICALS COM 53220K504 50,300 47,000 1,424.24 6,825 654.14 0.0346
2018-10-19 2018-09-30 13F LIGAND PHARMACEUTICALS COM 53220K504 3,300 700 26.92 905 68.22 0.0040
2018-08-06 2018-06-30 13F LIGAND PHARMACEUTICALS COM 53220K504 2,600 300 13.04 538 41.95 0.0023
2018-04-20 2018-03-31 13F LIGAND PHARMACEUTICALS COM 53220K504 2,300 600 35.29 379 63.36 0.0017
2018-01-23 2017-12-31 13F LIGAND PHARMACEUTICALS COM 53220K504 1,700 -19,200 -91.87 232 -91.85 0.0010
2017-10-23 2017-09-30 13F LIGAND PHARMACEUTICALS COM 53220K504 20,900 19,600 1,507.69 2,845 1,712.10 0.0122
2017-07-26 2017-06-30 13F LIGAND PHARMACEUTICALS COM 53220K504 1,300 900 225.00 157 273.81 0.0007
2017-04-26 2017-03-31 13F LIGAND PHARMACEUTICALS COM 53220K504 400 0 0.00 42 5.00 0.0002
2017-01-24 2016-12-31 13F LIGAND PHARMACEUTICALS COM 53220K504 400 -500 -55.56 40 -56.04 0.0002
2016-10-27 2016-09-30 13F LIGAND PHARMACEUTICALS COM 53220K504 900 -700 -43.75 91 -52.11 0.0004
2016-07-26 2016-06-30 13F LIGAND PHARMACEUTICALS COM 53220K504 1,600 1,000 166.67 190 196.88 0.0008
2016-04-25 2016-03-31 13F/A-1 LIGAND PHARMACEUTICALS COM 53220K504 600 -4,800 -88.89 64 -89.06 0.0003
2016-04-21 2016-03-31 13F LIGAND PHARMACEUTICALS COM 53220K504 600 64
2016-01-28 2015-12-31 13F LIGAND PHARMACEUTICALS COM 53220K504 5,400 -6,300 -53.85 585 -41.62 0.0026
2015-10-21 2015-09-30 13F LIGAND PHARMACEUTICALS COM 53220K504 11,700 11,700 0.00 1,002 0.0048
2015-04-27 2015-03-31 13F/A-1 LIGAND PHARMACEUTICALS COM 53220K504 0 -17,400 -100.00 0 -100.00
2015-01-23 2014-12-31 13F LIGAND PHARMACEUTICALS COM 53220K504 17,400 -1,500 -7.94 926 4.28 0.0040
2014-10-29 2014-09-30 13F/A-1 LIGAND PHARMACEUTICALS COM 53220K504 18,900 2,300 13.86 888 -14.12 0.0039
2014-10-20 2014-09-30 13F LIGAND PHARMACEUTICALS COM 53220K504 18,900 888
2014-07-24 2014-06-30 13F LIGAND PHARMACEUTICALS COM 53220K504 16,600 1,600 10.67 1,034 2.48 0.0046
2014-04-28 2014-03-31 13F LIGAND PHARMACEUTICALS COM 53220K504 15,000 -3,700 -19.79 1,009 2.54 0.0045
2014-01-30 2013-12-31 13F LIGAND PHARMACEUTICALS COM 53220K504 18,700 2,000 11.98 984 36.10 0.0044
2013-10-24 2013-09-30 13F LIGAND PHARMACEUTICALS COM 53220K504 16,700 16,700 723 0.0032
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.